Delivery Order SPE2DB22D3501-SPE2DB24FUT13
Award Date 2/28/24
Potential Completion Date 3/20/24
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical supplies. The $4,590.10 contract has a performance period through March 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designations were used. This delivery order is part of a larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,388.40 for Rhophylac 300 mcg/2 mL syringes under a firm fixed price contract. The award, issued December 31, 2025, with completion targeted for January 23, 2026, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes with a ceiling value of $1,720.80 and a firm fixed price structure. The contract is not set-aside and represents a competitive award to the pharmaceutical distributor. Performance will be completed by October 10, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,388.40 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Rhophylac 300 mcg/2 mL syringes. This firm fixed-price, competitively awarded contract calls for delivery to be completed by December 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Rhophylac 300 mcg/2 ml syringes in 2 ml quantities. This competitively awarded, non-set-aside contract is valued at $1,388.40 and operates under a firm fixed price structure, with an ultimate completion date of December 19, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $3,444.75 to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Rhophylac 300 mcg/2 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by February 20, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, demonstrating that AmerisourceBergen competed on a full and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $9,391.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, to Conshohocken, Pennsylvania by March 12, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, through its Corporate Office division, to provide a variety of pharmaceutical products and medical supplies valued at $3,158.36. The order has a completion date of February 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award and has an indefinite delivery contract with DLA valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $16,500.24 contract is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. This delivery order is issued under an existing indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $1,702.71 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide pharmaceutical products and medical supplies. The contract is a firm fixed price agreement with a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has also received an indefinite delivery contract from DLA, valued at up to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUT13Delivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,775.00 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML and has a performance period through March 20, 2024. This award is issued under Amerisourcebergen Drug Corp's single award indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a wide range of pharmaceutical products and medical supplies to military treatment programs and facilities. No set-aside designations were used for this specific delivery order.
Generated 5/29/24, 9:10 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 2/28/24 |